Trisomy 4 and de novo acute myelomonocytic leukemia in a Kuwaiti patient.
Trisomy 4 is a rare but specific karyotypic abnormality associated with primary and secondary acute myeloblastic leukemia (AML). We report such an occurrence in a Kuwaiti patient with de novo acute myelomonocytic leukemia and its disappearance on achievement of complete remission.
al-Bahar
S
S
Kuwait Cancer Control Centre, Shuwaikh.
Pandita
R
R
Owade
J M
JM
al Aasar
E M
EM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002871:Chromosome Banding; D002894:Chromosomes, Human, Pair 4; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007621:Karyotyping; D007730:Kuwait; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D014314:Trisomy
D003561:Cytarabine; D005047:Etoposide; D004317:Doxorubicin